Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Gene variation affects prostate issues and hair loss.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hair and skin healing involve complex cell interactions controlled by specific molecules and pathways, and hair follicle cells can help repair skin wounds.

Minoxidil helps lower severe blood pressure and promotes hair growth but can have serious side effects and must be used continuously.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Minoxidil can cause allergic skin reactions in some users.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

A married couple both developed a rare type of hair loss, possibly due to shared environmental factors.

Hypothyroidism in dogs is usually caused by immune system issues or gland atrophy, affects middle-aged purebreds most, and is treatable with medication.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

Finger length ratio may indicate male hair loss.